Bisdehydrodoisynolic acid
Bisdehydrodoisynolic acid (BDDA) is a synthetic, nonsteroidal estrogen that belongs to the class of estrogen receptor modulators. It is a derivative of doisynolic acid, which itself is a synthetic estrogen. BDDA has been studied for its potential use in hormone replacement therapy and other estrogen-related treatments.
Chemical Structure and Properties
BDDA is characterized by the removal of two hydrogen atoms from the parent compound, doisynolic acid, resulting in a more rigid structure. This modification enhances its binding affinity to the estrogen receptor, making it a potent estrogenic compound. The chemical formula of BDDA is C18H14O3.
Mechanism of Action
BDDA exerts its effects by binding to the estrogen receptors, which are intracellular proteins that mediate the physiological effects of estrogens. Upon binding, BDDA can mimic the action of natural estrogens, leading to the activation or repression of specific genes involved in various biological processes.
Pharmacokinetics
The pharmacokinetics of BDDA, including its absorption, distribution, metabolism, and excretion, have been studied in various animal models. BDDA is known to have a high oral bioavailability and a relatively long half-life, making it a suitable candidate for therapeutic use.
Therapeutic Applications
BDDA has been investigated for its potential use in several medical conditions, including:
- Hormone replacement therapy: BDDA may be used to alleviate symptoms associated with menopause, such as hot flashes and osteoporosis.
- Breast cancer: Due to its estrogenic activity, BDDA has been studied for its potential role in the treatment of hormone receptor-positive breast cancer.
- Cardiovascular health: Estrogens, including BDDA, have been shown to have protective effects on the cardiovascular system, potentially reducing the risk of heart disease.
Side Effects and Safety
As with other estrogenic compounds, BDDA may have side effects, including an increased risk of thrombosis, breast tenderness, and endometrial hyperplasia. Long-term safety studies are necessary to fully understand the risk profile of BDDA.
Research and Development
Ongoing research is focused on optimizing the therapeutic potential of BDDA, including the development of analogs with improved efficacy and safety profiles. Clinical trials are needed to establish the effectiveness of BDDA in various therapeutic applications.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD